Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Compounding pharmacies may face restrictions similar to what happened with compounded semaglutide when Ozempic faced shortage declarations and subsequent regulatory scrutiny
PMC (review synthesizing phase 1/2 data)
Early launches in certain countries have been supply constrained, so not all pharmacies stock it
Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Most Doubt the Trump Administration Will Lower Drug Costs for People Like Them, Though Three-Fourths of Republicans Expect It Will About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds
Start low and titrate slowly
Confirm what's included at your specific program tier and what the all-in monthly cost is
US$ 21.70
US$ 27.64
US$ 21.40
US$ 23.86
US$ 29.73
US$ 29.59
US$ 25.32
US$ 26.61
